Skip to content
10-Q

Quarterly Report

INTEGRA LIFESCIENCES HOLDINGS CORP IART

0000917520-26-000041

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 4, 2026 77.8M sh
Shares Diluted Q1 2026 · Mar 31, 2026 76.95M sh
Shares Diluted Q1 2026 · Mar 31, 2025 76.46M sh
Capex Q1 2026 · Mar 31, 2026 $14.85M
Capex Q1 2026 · Mar 31, 2025 $28.92M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $9.8M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$11.26M
Long Term Debt Q1 2026 · Mar 31, 2026 $716.88M
Short Term Investments Q1 2026 · Mar 31, 2026 $28.69M
Short Term Investments Q1 2026 · Dec 31, 2025 $28.69M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $236.81M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $235.05M
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.04B
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.04B
Stockholders Equity Q1 2026 · Mar 31, 2025 $1.52B
Stockholders Equity Q1 2026 · Dec 31, 2024 $1.55B
Current Liabilities Q1 2026 · Mar 31, 2026 $346.85M
Current Liabilities Q1 2026 · Dec 31, 2025 $455.98M
Total Liabilities Q1 2026 · Mar 31, 2026 $2.54B
Total Liabilities Q1 2026 · Dec 31, 2025 $2.56B
Current Assets Q1 2026 · Mar 31, 2026 $1.17B
Current Assets Q1 2026 · Dec 31, 2025 $1.16B
Total Assets Q1 2026 · Mar 31, 2026 $3.58B
Total Assets Q1 2026 · Dec 31, 2025 $3.6B
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.06
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.33
Eps Basic Q1 2026 · Mar 31, 2026 −$0.06
Eps Basic Q1 2026 · Mar 31, 2025 −$0.33
Sga Expense Q1 2026 · Mar 31, 2026 $178.24M
Sga Expense Q1 2026 · Mar 31, 2025 $181.5M
Net Income Q1 2026 · Mar 31, 2026 −$4.62M
Net Income Q1 2026 · Mar 31, 2025 −$25.29M
Operating Income Q1 2026 · Mar 31, 2026 $11.47M
Operating Income Q1 2026 · Mar 31, 2025 −$15.5M
Cost Of Revenue Q1 2026 · Mar 31, 2026 $174.94M
Cost Of Revenue Q1 2026 · Mar 31, 2025 $188.22M
Revenue Q1 2026 · Mar 31, 2026 $391.92M
Revenue Q1 2026 · Mar 31, 2025 $382.65M